DCF Advisers »

Vertex Pharmaceuticals Incorporated shares owned by DCF Advisers

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by DCF Advisers from 13F filings

Historical chart of DCF Advisers investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by DCF Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by DCF Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.9M 6.5k 453.36

More positions owned by DCF Advisers

Micron Technology (MU)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Alphabet Cap Stk Cl C (GOOG)
Teva Pharmaceutical-sp Adrs (TEVA)
Argenx Se Sponsored Adr (ARGX)
Vaneck Vectors Gold Miners Etf Etf (GDX)
Eli Lilly & Co. (LLY)
Ionis Pharmaceuticals (IONS)
Ishares Gold Tr Ishares New (IAU)
Regeneron Pharmaceuticals (REGN)
Amazon (AMZN)
Bank of America Corporation (BAC)
Advanced Micro Devices (AMD)
Cybin Com New (HELP)
Newamsterdam Pharma Company Ordinary Shares (NAMS)

View all positions for DCF Advisers

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Victory Capital Management
FMR
Jennison Associates
Norges Bank Investment Management

View all funds holding Vertex Pharmaceuticals Incorporated